Cogent Biosciences, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: COGT
Cogent Biosciences, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker COGT. It has reported private securities offerings to the US SEC, most recently $104 million sold in a notice filed in 2020.
Cogent Biosciences at a glance
What does Cogent Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $104.4 million sold (2020).
Frequently asked questions about Cogent Biosciences
Where is Cogent Biosciences headquartered?
Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Cogent Biosciences do?
Cogent Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Cogent Biosciences a public company?
Yes. Cogent Biosciences, Inc. trades on Nasdaq under the ticker COGT.
When was Cogent Biosciences founded?
The earliest incorporation on record for Cogent Biosciences, Inc. is in 2014, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.